[ET Net News Agency, 28 October 2021] Pharmaron Beijing Co., Ltd. (03759) said for the
third quarter of 2021, net profit attributable to owners of the parent was RMB475.23
million, a year-on-year increase of 53.26%.
Revenue was RMB2.02 billion, a year-on-year increase of 44.75%. (RC)